Login Register Cart 0
Generic placeholder image

Current Aging Science

Editor-in-Chief

ISSN (Print): 1874-6098
ISSN (Online): 1874-6128

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Helicobacter Pylori Interacts with Serum Vitamin D to Influence Hypertension

Author(s): Elie Salem-Sokhn, Ali Salami, Mirna Fawaz, Ali H. Eid and Said El Shamieh*

Volume 14, Issue 1, 2021

Published on: 25 September, 2020

Page: [26 - 31] Pages: 6

DOI: 10.2174/1874609813666200925104248

Price: $65

Abstract

Background and Objective: Hypertension is a multifactorial disease where numerous constitutive, genetic, and environmental factors interplay. Among the constitutive factors, age is a major determent continuously reported to be associated with a significant increase in the prevalence of hypertension. In addition to age, Helicobacter pylori (H. pylori) infection was also shown to be associated. On the other hand, Vitamin D (Vit D) plays an important role in the development of hypertension. In the current study, it was investigated whether H. pylori interacts with Vit D levels to influence hypertension.

Methods: This cross-sectional study was conducted on seven hundred and eighty-two “a priori” healthy individuals equally divided according to hypertension status. To study the association between Vit D, H. pylori, and hypertension, a multivariate logistic regression model was used while correcting for different confounding factors. Power analysis was also performed.

Results: Approximately half of the participants were hypertensive and had Vit D insufficiency and they were also matched for age. Using a multiple logistic regression model, the results showed an inversely proportionate association between H. pylori infection and the risk of hypertension (OR=0.38, P<0.001). On the other hand, a proportionate association between Vit D deficiency and hypertension was observed (OR=2.76, P=0.004). Furthermore, Vit D and H. pylori status interacted to affect the risk of hypertension (OR=0.97, P=0.004). Stratification, according to Vit D status, showed that 59.1% of Vit D deficient participants were infected with H. pylori organisms (P<0.001). When taking hypertension, Vit D, and H. pylori statuses into account, it was found that the prevalence of hypertension was doubled when the participants were negative for H. pylori infection but had Vit D deficiency (P<0.001).

Conclusion: H. pylori infection and Vit D deficiency could predict hypertension. The odds of hypertension development were double when the participants were negative for H. pylori infection and had vitamin D deficiency.

Keywords: Hypertension, Helicobacter pylori, serum vitamin D, association analysis, anthropometric, heterogenous.

« Previous Next »
Graphical Abstract

[1]
Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365(9455): 217-23.
[http://dx.doi.org/10.1016/S0140-6736(05)17741-1] [PMID: 15652604]
[2]
Liu B, Liu H, Na R, et al. A comparison on prevalence of hypertension and related risk factors between island and rural residents of dalian city, China. Int J Hypertens 2019; 2019: 6413102.
[http://dx.doi.org/10.1155/2019/6413102] [PMID: 31214361]
[3]
Buford TW. Hypertension and aging. Ageing Res Rev 2016; 26: 96-111.
[http://dx.doi.org/10.1016/j.arr.2016.01.007] [PMID: 26835847]
[4]
Franceschi C, Motta L, Motta M, et al. IMUSCE. The extreme longevity: the state of the art in Italy. Exp Gerontol 2008; 43(2): 45-52.
[http://dx.doi.org/10.1016/j.exger.2007.06.006] [PMID: 17703905]
[5]
Troen BR. The biology of aging. Mt Sinai J Med 2003; 70(1): 3-22.
[PMID: 12516005]
[6]
Lee CJ, Kim JY, Shim E, et al. The effects of diet alone or in combination with exercise in patients with prehypertension and hypertension: A randomized controlled trial. korean Circ J 2018; 48(7): 637-51.
[http://dx.doi.org/10.4070/kcj.2017.0349] [PMID: 29968437]
[7]
Migneco A, Ojetti V, Specchia L, et al. Eradication of Helicobacter pylori infection improves blood pressure values in patients affected by hypertension. Helicobacter 2003; 8(6): 585-9.
[http://dx.doi.org/10.1111/j.1523-5378.2003.00180.x] [PMID: 14632672]
[8]
Wan Z, Hu L, Hu M, Lei X, Huang Y, Lv Y. Helicobacter pylori infection and prevalence of high blood pressure among Chinese adults. J Hum Hypertens 2018; 32(2): 158-64.
[http://dx.doi.org/10.1038/s41371-017-0028-8] [PMID: 29289960]
[9]
Martínez Torres A, Martínez Gaensly M. Helicobacter pylori: A new cardiovascular risk factor. Rev Esp Cardiol 2002; 55(6): 652-6.
[http://dx.doi.org/10.1016/S0300-8932(02)76673-6] [PMID: 12113724]
[10]
Burucoa C, Axon A. Epidemiology of helicobacter pylori infection. Helicobacter 2017; 22(1).
[http://dx.doi.org/10.1111/hel.12403]
[11]
Naja F, Nasreddine L, Hwalla N, et al. Association of H. pylori infection with insulin resistance and metabolic syndrome among Lebanese adults. Helicobacter 2012; 17(6): 444-51.
[http://dx.doi.org/10.1111/j.1523-5378.2012.00970.x] [PMID: 23066847]
[12]
Sizar O, Givler A. Vitamin D Deficiency. Treasure Island, FL: StatPearls 2019.
[13]
Legarth C, Grimm D, Wehland M, Bauer J, Krüger M. The impact of vitamin D in the treatment of essential hypertension. Int J Mol Sci 2018; 19(2): E455.
[http://dx.doi.org/10.3390/ijms19020455] [PMID: 29401665]
[14]
Geleijnse JM. Vitamin D and the prevention of hypertension and cardiovascular diseases: A review of the current evidence. Am J Hypertens 2011; 24(3): 253-62.
[http://dx.doi.org/10.1038/ajh.2010.199] [PMID: 20847727]
[15]
Shamardl HA, El-Ashmony SM, Kamel HF, Fatani SH. Potential cardiovascular and renal protective effects of vitamin D and coenzyme Q10 in l-name-induced hypertensive rats. Am J Med Sci 2017; 354(2): 190-8.
[http://dx.doi.org/10.1016/j.amjms.2017.04.007] [PMID: 28864378]
[16]
Assaad S, Costanian C, Jaffal L, Tannous F, Stathopoulou MG, El Shamieh S. Association of tlr4 polymorphisms, expression, and vitamin D with Helicobacter pylori infection. J Pers Med 2019; 9(1): E2.
[http://dx.doi.org/10.3390/jpm9010002] [PMID: 30641993]
[17]
Du C, Yang S, Zhao X, Dong H. Pathogenic roles of alterations in vitamin D and vitamin D receptor in gastric tumorigenesis. Oncotarget 2017; 8(17): 29474-86.
[http://dx.doi.org/10.18632/oncotarget.15298] [PMID: 28206978]
[18]
Alghalyini B, El Shamieh S, Salami A, Visvikis Siest S, Fakhoury HM, Fakhoury R. Effect of SLCO1B1 gene polymorphisms and vitamin D on statin-induced myopathy. Drug Metab Pers Ther 2018; 33(1): 41-7.
[http://dx.doi.org/10.1515/dmpt-2017-0030] [PMID: 29420305]
[19]
Ramezankhani A, Azizi F, Hadaegh F. Associations of marital status with diabetes, hypertension, cardiovascular disease and all-cause mortality: A long term follow-up study. PLoS One 2019; 14(4): e0215593.
[http://dx.doi.org/10.1371/journal.pone.0215593] [PMID: 31009512]
[20]
Bloch MJ. Worldwide prevalence of hypertension exceeds 1.3 billion. J Am Soc Hypertens 2016; 10(10): 753-4.
[http://dx.doi.org/10.1016/j.jash.2016.08.006] [PMID: 27660007]
[21]
Chiorean MV, Locke GR III, Zinsmeister AR, Schleck CD, Melton LJ III. Changing rates of Helicobacter pylori testing and treatment in patients with peptic ulcer disease. Am J Gastroenterol 2002; 97(12): 3015-22.
[http://dx.doi.org/10.1111/j.1572-0241.2002.07119.x] [PMID: 12492184]
[22]
Parva NR, Tadepalli S, Singh P, et al. Prevalence of vitamin D deficiency and associated risk factors in the us population. Cureus 2018; 10(6): e2741.
[http://dx.doi.org/10.7759/cureus.2741] [PMID: 30087817]
[23]
Vinutha SMS, Kutty AVM, Annamalai N. Helicobacter pylori infection and hypertension: Is there an association? Biomed Res Biomedical Research (India) 2012; 23(4): 537-9.
[24]
Kopacova M, Koupil I, Seifert B, et al. Blood pressure and stature in Helicobacter pylori positive and negative persons. World J Gastroenterol 2014; 20(19): 5625-31.
[http://dx.doi.org/10.3748/wjg.v20.i19.5625] [PMID: 24914321]
[25]
Jeong HY, Park KM, Lee MJ, Yang DH, Kim SH, Lee SY. Vitamin D and Hypertension. Electrolyte Blood Press 2017; 15(1): 1-11.
[http://dx.doi.org/10.5049/EBP.2017.15.1.1] [PMID: 29042901]
[26]
Vaidya A, Forman JP. Vitamin D and hypertension: Current evidence and future directions. Hypertension 2010; 56(5): 774-9.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.109.140160] [PMID: 20937970]
[27]
Yildirim O, Yildirim T, Seckin Y, Osanmaz P, Bilgic Y, Mete R. The influence of vitamin D deficiency on eradication rates of Helicobacter pylori. Adv Clin Exp Med 2017; 26(9): 1377-81.
[http://dx.doi.org/10.17219/acem/65430] [PMID: 29442458]

Rights & Permissions Print Cite
Article Metrics
26
2
© 2024 Bentham Science Publishers | Privacy Policy